Elagolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist used to manage moderate to severe pain associated with endometriosis by reducing estrogen production. It is grouped under the following drug class(es): LHRH analogues. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Orilissa and elagolixum. Its PubChem CID is 11250647.
Elagolix
| CAS No | 834153-87-6 |
|---|---|
| Molecular Formula | C32H30F5N3O5 |
| Molecular Weight | 631.6 g/mol |
| Synonyms | 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Elagolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist used to manage moderate to severe pain associated with endometriosis by reducing estrogen production.
The listed CAS number is 834153-87-6.
The listed molecular formula is C32H30F5N3O5.
The listed molecular weight is 631.6 g/mol.
4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoic acid.
The source lists Orilissa and elagolixum.